Testing Resources for Mpox
AMP has assembled a list of available resources on testing for Mpox. This page will change as new information becomes available. Please check back frequently for updates.
As a reminder for AMP Members, feel free to use the CHAMP community when you have questions for your AMP colleagues regarding Mpox.
AMP
Mpox Outbreak Maps
AMA
APHL
Association for Professionals in Infection Control and Epidemiology (APIC)
ASM
ASPR
CDC
- Tips For Adequate Collection of a Lesion Specimen From a Suspect Mpox Virus Case
- Case Definitions for Use in the 2022 Mpox Response
- Preparation and Collection of Specimens
- Diagnostic Process for Mpox virus Testing for Non-LRN Laboratories
- Occupational Exposure to Orthopoxviruses Among Laboratory Personnel
- Health Alert Network (HAN)
- Morbidity and Mortality Weekly Report (MMWR)
- Mpox in a Young Infant — Florida, 2022
- High-Contact Object and Surface Contamination in a Household of Persons with Mpox Virus Infection — Utah, June 2022
- Epidemiologic and Clinical Characteristics of Mpox Cases — United States, May 17–July 22, 2022
- Interim Guidance for Prevention and Treatment of Mpox in Persons with HIV Infection — United States, August 2022
- Rapid Diagnostic Testing for Response to the Mpox Outbreak — Laboratory Response Network, United States, May 17–June 30, 2022
- Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 NOTE: erratum published
- Mpox Outbreak — Nine States, May 2022
- Orthopoxvirus Testing Challenges for Persons in Populations at Low Risk or Without Known Epidemiologic Link to Mpox — United States, 2022
- Two Cases of Mpox-Associated Encephalomyelitis — Colorado and the District of Columbia, July–August 2022
- Health Care Personnel Exposures to Subsequently Laboratory-Confirmed Mpox Patients — Colorado, 2022
- 2022 U.S. Mpox Outbreak – Situation Summary
- Mpox Information For Laboratory Personnel
- Laboratory Process for Mpox Virus Testing
- Laboratory Procedures and Biosafety Guidelines
- How to Report Results from Orthopoxvirus, Non-Variola Orthopoxvirus, and Mpox Virus Laboratory Diagnostic Testing
- Real-Time PCR Assays
FDA
United Kingdom Health Security Agency (UK HSA)
European Society of Clinical Microbiology and Infectious Diseases
Public Health Agency of Canada (PHAC)
IDSA
WHO
Other Resources
Center for Infectious Disease Research and Policy (CIDRAP), Univ of Minnesota
European Centre for Disease Prevention and Control (ECDC)
Disclaimer: With the exception of resources labeled above as having been generated by AMP, links will take you to external websites. Resources above are the sole responsibility of the entity providing them. AMP does not endorse any commercial product or service. AMP makes no warranty, express or implied, regarding any commercial product or service, and hereby disclaims, the accuracy, completeness, timeliness or merchantability or fitness for a particular purpose of the content and associated materials presented above. AMP shall not be liable for any damages, including direct, indirect, special, incidental, or consequential or any other type of damages arising out of or related to the use of the information contained on this page or associated materials.